BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32638549)

  • 1. Spectrum of gene mutations identified by targeted next-generation sequencing in Chinese leukemia patients.
    Yao H; Wu C; Chen Y; Guo L; Chen W; Pan Y; Fu X; Wang G; Ding Y
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1369. PubMed ID: 32638549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia.
    Duncavage EJ; Abel HJ; Szankasi P; Kelley TW; Pfeifer JD
    Mod Pathol; 2012 Jun; 25(6):795-804. PubMed ID: 22425908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma.
    Ding Y; Yao J; Wen M; Liu X; Huang J; Zhang M; Zhang Y; Lv Y; Xie Z; Zuo J
    PeerJ; 2022; 10():e13473. PubMed ID: 35602894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cruxome: a powerful tool for annotating, interpreting and reporting genetic variants.
    Han Q; Yang Y; Wu S; Liao Y; Zhang S; Liang H; Cram DS; Zhang Y
    BMC Genomics; 2021 Jun; 22(1):407. PubMed ID: 34082700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application value of whole exome sequencing in screening and identifying novel mutations of hypopharyngeal cancer.
    Yao J; Ding Y; Liu X; Huang J; Zhang M; Zhang Y; Lv Y; Xie Z; Zuo J
    Sci Rep; 2023 Jan; 13(1):107. PubMed ID: 36596842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing.
    Lee PJ; Yoo NS; Hagemann IS; Pfeifer JD; Cottrell CE; Abel HJ; Duncavage EJ
    Exp Mol Pathol; 2017 Feb; 102(1):156-161. PubMed ID: 28093192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
    Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
    J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance Mechanisms to Targeted Therapies in
    McCoach CE; Le AT; Gowan K; Jones K; Schubert L; Doak A; Estrada-Bernal A; Davies KD; Merrick DT; Bunn PA; Purcell WT; Dziadziuszko R; Varella-Garcia M; Aisner DL; Camidge DR; Doebele RC
    Clin Cancer Res; 2018 Jul; 24(14):3334-3347. PubMed ID: 29636358
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular and prenatal diagnosis of a family with Fanconi anemia by next generation sequencing].
    Gong Z; Yu Y; Zhang Q; Gu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):204-7. PubMed ID: 25863087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer.
    Wang SR; Malik S; Tan IB; Chan YS; Hoi Q; Ow JL; He CZ; Ching CE; Poh DYS; Seah HM; Cheung KHT; Perumal D; Devasia AG; Pan L; Ang S; Lee SE; Ten R; Chua C; Tan DSW; Qu JZZ; Bylstra YM; Lim L; Lezhava A; Ng PC; Wong CW; Lim T; Tan P
    J Mol Diagn; 2016 May; 18(3):416-424. PubMed ID: 26970585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide variants and InDels identified from whole-genome re-sequencing of Guzerat, Gyr, Girolando and Holstein cattle breeds.
    Stafuzza NB; Zerlotini A; Lobo FP; Yamagishi ME; Chud TC; Caetano AR; Munari DP; Garrick DJ; Machado MA; Martins MF; Carvalho MR; Cole JB; Barbosa da Silva MV
    PLoS One; 2017; 12(3):e0173954. PubMed ID: 28323836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
    BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of pathogenic variants from the ClinVar database in healthy people using next-generation sequencing.
    Rančelis T; Arasimavičius J; Ambrozaitytė L; Kavaliauskienė I; Domarkienė I; Karčiauskaitė D; Kučinskienė ZA; Kučinskas V
    Genet Res (Camb); 2017 Aug; 99():e6. PubMed ID: 28851476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms.
    Vandamme T; Beyens M; Boons G; Schepers A; Kamp K; Biermann K; Pauwels P; De Herder WW; Hofland LJ; Peeters M; Van Camp G; Op de Beeck K
    Endocr Relat Cancer; 2019 Jan; 26(1):1-12. PubMed ID: 30021865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of RNA- and exome sequencing: Increasing specificity for identification of somatic point mutations and indels in acute leukaemia.
    Hansen MC; Herborg LL; Hansen M; Roug AS; Hokland P
    Leuk Res; 2016 Dec; 51():27-31. PubMed ID: 27821287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
    Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
    Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of rare heterozygous missense mutations in FANCA in esophageal atresia patients using next-generation sequencing.
    Feng Y; Chen R; Da M; Qian B; Mo X
    Gene; 2018 Jun; 661():182-188. PubMed ID: 29621589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
    Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
    Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.